| Product Code: ETC13272976 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Endovascular Treatment Market was valued at USD 10.4 Billion in 2024 and is expected to reach USD 18.6 Billion by 2031, growing at a compound annual growth rate of 8.40% during the forecast period (2025-2031).
The Global Endovascular Treatment Market is witnessing significant growth due to the rising prevalence of cardiovascular diseases, technological advancements in minimally invasive procedures, and increasing adoption of endovascular treatments over traditional open surgeries. The market includes a wide range of endovascular devices such as stents, catheters, guidewires, and embolic protection devices used in the treatment of conditions like peripheral artery disease, aneurysms, and deep vein thrombosis. North America dominates the market due to high healthcare expenditure and advanced healthcare infrastructure, while the Asia-Pacific region is expected to witness rapid growth driven by improving healthcare facilities and increasing investment in healthcare. Key players in the market include Medtronic, Abbott Laboratories, Boston Scientific Corporation, and Cook Medical, among others, who are constantly innovating and launching new products to meet the growing demand for endovascular treatments.
The Global Endovascular Treatment Market is experiencing significant growth due to the rising prevalence of cardiovascular diseases and the increasing adoption of minimally invasive procedures. Key trends include the development of advanced endovascular devices, such as stents and catheters, to improve treatment outcomes and reduce procedural complications. Opportunities in the market are driven by the growing geriatric population, technological advancements in imaging and navigation systems, and expanding healthcare infrastructure in emerging economies. Additionally, the shift towards value-based healthcare and the rising demand for outpatient procedures are driving the market forward. Companies are focusing on strategic collaborations, mergers, and acquisitions to enhance their product portfolios and expand their market presence in this competitive landscape.
The Global Endovascular Treatment Market faces several challenges, including stringent regulatory requirements for product approvals, high costs associated with endovascular procedures, and limited availability of skilled professionals to perform these specialized treatments. Additionally, there is a growing concern regarding the long-term durability and efficacy of endovascular devices, leading to some reluctance among healthcare providers and patients to fully embrace these treatments. Market competition is intense, with established players and new entrants vying for market share, leading to pricing pressures and the need for continuous innovation. Moreover, the complexity of endovascular procedures and the potential for adverse events pose significant challenges in ensuring patient safety and positive outcomes, further emphasizing the importance of thorough training and ongoing research in this field.
The Global Endovascular Treatment Market is primarily driven by factors such as the increasing prevalence of cardiovascular diseases, technological advancements in endovascular procedures, rising demand for minimally invasive surgeries, and growing elderly population worldwide. The shift towards endovascular treatments from traditional open surgeries due to their benefits such as shorter recovery time, lower risk of complications, and reduced hospital stays is also fueling market growth. Additionally, the expanding healthcare infrastructure in developing countries, favorable reimbursement policies, and the growing focus on early diagnosis and treatment of vascular diseases are further contributing to the market expansion. The continuous research and development activities in the field of endovascular treatments are expected to drive innovation and propel market growth in the coming years.
Government policies related to the Global Endovascular Treatment Market focus on regulating the safety, efficacy, and accessibility of endovascular procedures and devices. Regulatory bodies such as the FDA in the United States and the European Medicines Agency in the EU oversee the approval process for endovascular devices, ensuring they meet stringent quality and safety standards before entering the market. Additionally, reimbursement policies play a crucial role in market dynamics, with government healthcare systems determining coverage and payment rates for endovascular treatments. Policies aimed at promoting innovation, cost-effectiveness, and patient outcomes drive market growth, while also addressing concerns around patient safety and healthcare affordability. Continued collaboration between government agencies, healthcare providers, and industry stakeholders is vital for shaping a favorable regulatory environment that supports the advancement of endovascular treatments worldwide.
The Global Endovascular Treatment Market is poised for significant growth in the coming years due to the increasing prevalence of cardiovascular diseases, technological advancements in minimally invasive procedures, and rising demand for efficient and cost-effective treatment options. Factors such as the growing elderly population, changing lifestyle habits, and expanding healthcare infrastructure in emerging economies are also expected to drive market expansion. Furthermore, advancements in endovascular devices and techniques, coupled with the rising adoption of endovascular procedures over traditional open surgeries, are projected to boost market growth. However, market growth may be hindered by regulatory challenges, high procedural costs, and potential complications associated with endovascular treatments. Overall, the market is anticipated to witness steady growth as endovascular treatments continue to gain traction as a preferred option for various vascular conditions globally.
In Asia, the endovascular treatment market is rapidly growing due to increasing healthcare expenditure, rising prevalence of chronic diseases, and improving healthcare infrastructure. North America dominates the market with a high adoption rate of advanced endovascular procedures, technological advancements, and favorable reimbursement policies. In Europe, the market is driven by the growing aging population and increasing cases of cardiovascular diseases. The Middle East and Africa region is experiencing steady growth in endovascular treatments, supported by government initiatives to improve healthcare access and infrastructure. Latin America shows potential for market growth due to the rising awareness about minimally invasive procedures and increasing healthcare investments in countries like Brazil and Mexico. Overall, the global endovascular treatment market is expected to continue expanding across all regions.
Global Endovascular Treatment Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Endovascular Treatment Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Endovascular Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Global Endovascular Treatment Market - Industry Life Cycle |
3.4 Global Endovascular Treatment Market - Porter's Five Forces |
3.5 Global Endovascular Treatment Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Endovascular Treatment Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 Global Endovascular Treatment Market Revenues & Volume Share, By Procedure, 2021 & 2031F |
3.8 Global Endovascular Treatment Market Revenues & Volume Share, By pplication, 2021 & 2031F |
3.9 Global Endovascular Treatment Market Revenues & Volume Share, By End user, 2021 & 2031F |
4 Global Endovascular Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Endovascular Treatment Market Trends |
6 Global Endovascular Treatment Market, 2021 - 2031 |
6.1 Global Endovascular Treatment Market, Revenues & Volume, By Product, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Endovascular Treatment Market, Revenues & Volume, By Percutaneous endovascular aneurysm repair (EVAR), 2021 - 2031 |
6.1.3 Global Endovascular Treatment Market, Revenues & Volume, By Fenestrated EVAR, 2021 - 2031 |
6.1.4 Global Endovascular Treatment Market, Revenues & Volume, By Aortic stents Biodegradable Stents, 2021 - 2031 |
6.1.5 Global Endovascular Treatment Market, Revenues & Volume, By Self-expanding Nitinol Stents, 2021 - 2031 |
6.1.6 Global Endovascular Treatment Market, Revenues & Volume, By Thoracic aortic aneurysms grafts, 2021 - 2031 |
6.1.7 Global Endovascular Treatment Market, Revenues & Volume, By Other, 2021 - 2031 |
6.2 Global Endovascular Treatment Market, Revenues & Volume, By Procedure, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Endovascular Treatment Market, Revenues & Volume, By Balloon Angioplasty, 2021 - 2031 |
6.2.3 Global Endovascular Treatment Market, Revenues & Volume, By Angioplasty with Stent Placement, 2021 - 2031 |
6.2.4 Global Endovascular Treatment Market, Revenues & Volume, By Transfemoral Carotid Artery Stenting, 2021 - 2031 |
6.2.5 Global Endovascular Treatment Market, Revenues & Volume, By Transcarotid Artery Revascularization, 2021 - 2031 |
6.2.6 Global Endovascular Treatment Market, Revenues & Volume, By Renal Artery Angioplasty and Stenting, 2021 - 2031 |
6.2.7 Global Endovascular Treatment Market, Revenues & Volume, By Carotid Artery Stenting, 2021 - 2031 |
6.3 Global Endovascular Treatment Market, Revenues & Volume, By pplication, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Endovascular Treatment Market, Revenues & Volume, By Pulmonary, 2021 - 2031 |
6.3.3 Global Endovascular Treatment Market, Revenues & Volume, By Vascular, 2021 - 2031 |
6.3.4 Global Endovascular Treatment Market, Revenues & Volume, By Cardiology Surgery, 2021 - 2031 |
6.3.5 Global Endovascular Treatment Market, Revenues & Volume, By Neurology, 2021 - 2031 |
6.3.6 Global Endovascular Treatment Market, Revenues & Volume, By Radiology, 2021 - 2031 |
6.4 Global Endovascular Treatment Market, Revenues & Volume, By End user, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Endovascular Treatment Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.4.3 Global Endovascular Treatment Market, Revenues & Volume, By Ambulatory Surgical Center, 2021 - 2031 |
6.4.4 Global Endovascular Treatment Market, Revenues & Volume, By Clinics, 2021 - 2031 |
7 North America Endovascular Treatment Market, Overview & Analysis |
7.1 North America Endovascular Treatment Market Revenues & Volume, 2021 - 2031 |
7.2 North America Endovascular Treatment Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Endovascular Treatment Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Endovascular Treatment Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Endovascular Treatment Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Endovascular Treatment Market, Revenues & Volume, By Product, 2021 - 2031 |
7.4 North America Endovascular Treatment Market, Revenues & Volume, By Procedure, 2021 - 2031 |
7.5 North America Endovascular Treatment Market, Revenues & Volume, By pplication, 2021 - 2031 |
7.6 North America Endovascular Treatment Market, Revenues & Volume, By End user, 2021 - 2031 |
8 Latin America (LATAM) Endovascular Treatment Market, Overview & Analysis |
8.1 Latin America (LATAM) Endovascular Treatment Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Endovascular Treatment Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Endovascular Treatment Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Endovascular Treatment Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Endovascular Treatment Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Endovascular Treatment Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Endovascular Treatment Market, Revenues & Volume, By Product, 2021 - 2031 |
8.4 Latin America (LATAM) Endovascular Treatment Market, Revenues & Volume, By Procedure, 2021 - 2031 |
8.5 Latin America (LATAM) Endovascular Treatment Market, Revenues & Volume, By pplication, 2021 - 2031 |
8.6 Latin America (LATAM) Endovascular Treatment Market, Revenues & Volume, By End user, 2021 - 2031 |
9 Asia Endovascular Treatment Market, Overview & Analysis |
9.1 Asia Endovascular Treatment Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Endovascular Treatment Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Endovascular Treatment Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Endovascular Treatment Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Endovascular Treatment Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Endovascular Treatment Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Endovascular Treatment Market, Revenues & Volume, By Product, 2021 - 2031 |
9.4 Asia Endovascular Treatment Market, Revenues & Volume, By Procedure, 2021 - 2031 |
9.5 Asia Endovascular Treatment Market, Revenues & Volume, By pplication, 2021 - 2031 |
9.6 Asia Endovascular Treatment Market, Revenues & Volume, By End user, 2021 - 2031 |
10 Africa Endovascular Treatment Market, Overview & Analysis |
10.1 Africa Endovascular Treatment Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Endovascular Treatment Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Endovascular Treatment Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Endovascular Treatment Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Endovascular Treatment Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Endovascular Treatment Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Endovascular Treatment Market, Revenues & Volume, By Product, 2021 - 2031 |
10.4 Africa Endovascular Treatment Market, Revenues & Volume, By Procedure, 2021 - 2031 |
10.5 Africa Endovascular Treatment Market, Revenues & Volume, By pplication, 2021 - 2031 |
10.6 Africa Endovascular Treatment Market, Revenues & Volume, By End user, 2021 - 2031 |
11 Europe Endovascular Treatment Market, Overview & Analysis |
11.1 Europe Endovascular Treatment Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Endovascular Treatment Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Endovascular Treatment Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Endovascular Treatment Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Endovascular Treatment Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Endovascular Treatment Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Endovascular Treatment Market, Revenues & Volume, By Product, 2021 - 2031 |
11.4 Europe Endovascular Treatment Market, Revenues & Volume, By Procedure, 2021 - 2031 |
11.5 Europe Endovascular Treatment Market, Revenues & Volume, By pplication, 2021 - 2031 |
11.6 Europe Endovascular Treatment Market, Revenues & Volume, By End user, 2021 - 2031 |
12 Middle East Endovascular Treatment Market, Overview & Analysis |
12.1 Middle East Endovascular Treatment Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Endovascular Treatment Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Endovascular Treatment Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Endovascular Treatment Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Endovascular Treatment Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Endovascular Treatment Market, Revenues & Volume, By Product, 2021 - 2031 |
12.4 Middle East Endovascular Treatment Market, Revenues & Volume, By Procedure, 2021 - 2031 |
12.5 Middle East Endovascular Treatment Market, Revenues & Volume, By pplication, 2021 - 2031 |
12.6 Middle East Endovascular Treatment Market, Revenues & Volume, By End user, 2021 - 2031 |
13 Global Endovascular Treatment Market Key Performance Indicators |
14 Global Endovascular Treatment Market - Export/Import By Countries Assessment |
15 Global Endovascular Treatment Market - Opportunity Assessment |
15.1 Global Endovascular Treatment Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Endovascular Treatment Market Opportunity Assessment, By Product, 2021 & 2031F |
15.3 Global Endovascular Treatment Market Opportunity Assessment, By Procedure, 2021 & 2031F |
15.4 Global Endovascular Treatment Market Opportunity Assessment, By pplication, 2021 & 2031F |
15.5 Global Endovascular Treatment Market Opportunity Assessment, By End user, 2021 & 2031F |
16 Global Endovascular Treatment Market - Competitive Landscape |
16.1 Global Endovascular Treatment Market Revenue Share, By Companies, 2024 |
16.2 Global Endovascular Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |